CD8+ T cells take a leading position in anti-tumor response among the tumor-infiltrated immune cells and activated effector T cells in the TME mainly depend on glycolysis and FAS, while memory T cells and CD4+ regulatory T cells maintain their functions by enhancing FAO (169). The gene discussed is CD8A; the disease is neoplasm.